BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  UroGen Pharma to Host Third Quarter 2017 Financial Results Conference Call on Tuesday, November 14, 2017

  The Company’s third quarter 2017 financial results will be released prior to the call.

  November 8, 2017

   · 

  1 min read
• Drug Development

  Immunovaccine Announces Regulatory Clearance for Phase II Clinical Trial Evaluating DPX-Survivac in Combination With Merck’s Checkpoint Inhibitor Pembrolizumab in DLBCL

  This trial is designed to evaluate the safety and efficacy of Immunovaccine’s lead candidate along with Merck’s pembrolizumab and low-dose cyclophosphamide in this patient population.

  November 8, 2017

   · 

  5 min read
• Business

  Clearside Biomedical Announces Third Quarter 2017 Financial Results and Provides Corporate Update

  Clearside’s research and development expenses for the three months ended September 30, 2017 were $16.1 million, compared to $3.7 million for the third quarter of 2016.

  November 8, 2017

   · 

  9 min read
• Business

  Kamada to Announce Third Quarter 2017 Financial Results and Host Conference Call on November 13

  Management will host an investment community conference call on Monday, November 13, at 8:30am ET.

  November 8, 2017

   · 

  3 min read
• Business

  Chimerix Announces Third Quarter 2017 Financial Results

  Chimerix reported a net loss of $17.3 million, or $0.37 per basic and diluted share, for the third quarter of 2017.

  November 8, 2017

   · 

  8 min read
• Business

  Awair Partners With Brown University to Study Effects of Environmental Exposures on Neurodevelopment in Children

  Awair today announces its partnership with Brown University’s Baby Imaging Lab to collaborate on a NIH-sponsored project called “Resonance”, a longitudinal study that focuses on understanding how a wide variety of environmental exposures affect child neurodevelopment.

  November 8, 2017

   · 

  2 min read
• Business

  Amicus Therapeutics Announces Third Quarter 2017 Financial Results and Corporate Updates

  The Company also summarized recent program updates and reiterated full-year 2017 financial guidance.

  November 8, 2017

   · 

  17 min read
• Biotech Beach

  Vical Incorporated Announces Pricing of $25M Underwritten Public Offering of Common Stock

  H.C. Wainwright & Co., LLC is acting as the sole book-running manager for the offering.

  November 8, 2017

   · 

  2 min read
• Business

  REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services

  Science Exchange announced today that ReproCELL has selected the Science Exchange platform as the primary marketplace to offer access to its predictive drug discovery assays for the biopharma research community.

  November 8, 2017

   · 

  3 min read
• Business

  Lundbeck Increased Operating Profit (EBIT) With 126% and EPS by 182% in the First Nine Months of 2017

  Revenue reached DKK 12,842 million in the first nine months of 2017 representing an increase of 12% (13% in local currencies) compared to the same period last year.

  November 8, 2017

   · 

  2 min read